Research and Clinical Trials

Title  
Partner 3
Brief Description  
The purpose of this study is to establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve in patients with severe, symptomatic aortic stenosis who are at low operative risk for standard aortic valve replacement (AVR).
Who may be Eligible  
Patients 65 years and older with symptomoatic, severe, calcific aortic stenosis..
Start Date  
07/28/2016
IRB Number  
05-16-10A
Principal Investigator  
Rinaldi, Michael
Contact Name  
Sally

For More Information, Contact   Sally  Krueger , RN
Phone:  (704) 355-4797  Fax:  (704) 355-7264 
Email:  SHVIClinicalResearch@carolinashealthcare.org
Address:  1001 Blythe Blvd
MCP-M-201
Charlotte, NC 28203
Close